Cargando…
Cost and appropriateness of treating asthma with fixed-combination drugs in local health care units in Italy
BACKGROUND: Bronchial asthma is a chronic airways disease and is considered to be one of the major health problems in the Western world. During the last decade, a significant increase in the use of β2-agonists in combination with inhaled corticosteroids has been observed. The aim of this study was t...
Autores principales: | Ruggeri, Isabella, Bragato, Donatello, Colombo, Giorgio L, Valla, Emanuela, Di Matteo, Sergio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3519004/ https://www.ncbi.nlm.nih.gov/pubmed/23233808 http://dx.doi.org/10.2147/CEOR.S36499 |
Ejemplares similares
-
Omalizumab for Severe Allergic Asthma Treatment in Italy: A Cost-Effectiveness Analysis from PROXIMA Study
por: Canonica, Giorgio Walter, et al.
Publicado: (2020) -
Cost of persistent asthma in Italy
por: Dal Negro, Roberto W., et al.
Publicado: (2016) -
A cost-effectiveness analysis of different therapies in patients with chronic hepatitis B in Italy
por: Colombo, Giorgio L, et al.
Publicado: (2011) -
A cost–utility analysis of etanercept for the treatment of moderate-to-severe psoriasis in Italy
por: Colombo, Giorgio L, et al.
Publicado: (2009) -
Shadow cost of oral corticosteroids-related adverse events: A pharmacoeconomic evaluation applied to real-life data from the Severe Asthma Network in Italy (SANI) registry
por: Canonica, Giorgio Walter, et al.
Publicado: (2019)